Your mission
We are seeking an MR Sequence Developer (m/w/d) with a strong background in MR sequence development, MR physics, and hyperpolarized MRI. You will play a central role in developing our sequence package for hyperpolarized MRI. As a Sequence Developer, you will collaborate closely with our academic partners to develop and implement cutting-edge MR sequences for hyperpolarized MRI. In doing so, you can draw on your experience to identify possible applications and also adjust to important hardware considerations.
Responsibilities:
As an experienced MR Sequence Developer you can draw on your extensive knowledge of MR software development, hyperpolarized MRI, and MR physics, while collaborating effectively within a team environment.
You will efficiently implement and develop sequences for hyperpolarized MRI in collaboration with our academic partners and drive research developments in-house and at the research sites.
You will set up hyperpolarized scans, run thorough quality assurance and quality control, while utilizing your expertise in MR hardware, including coils and phantoms.
contact information
Join us in making a difference! Submit your application to be considered for this exciting opportunity.
Emilija Stojanovska
Talent Acquisition Manager
Email: jobs@nvision-imaging.com
About us
NVision is a quantum biotech startup based in Ulm, Germany, with Tier 1 investors from the USA and Europe. We are just leaving stealth mode, moving from local R&D to global commercialization and expansion.
We are developing a technology that will enable MRI-based imaging of real-time metabolism in the body, with tremendous potential for research and applications in oncology, cardiology, neurology and more. Our company brings together expertise in physics, chemistry, engineering and medicine, and we are collaborating with scientists and clinicians from top medical and research centers such as Memorial Sloan Kettering in New York, MD Anderson in Texas, Technical University of Munich, Cambridge University in the UK and more.
NVision is developing fast, robust and easy-to-use hyperpolarization technology for preclinical and clinical research in our Polaris product line. Those devices are placed close to an MRI scanner in a clinical environment or a research lab to produce hyperpolarized contrast agents on demand. The hyperpolarized solution is prepared in a fast, fully-automated, multi-step process including chemical reactions, polarization transfer and several purification steps. We develop our commercial products in close collaboration with a product development partner, while the process development as well as the design of test setups and prototypes is done in-house.
We offer a dynamic international working environment, with immense room for growth, that encourages personal initiative and open communication.
